Quantel Medical announced the launch of LacryDiag, a complete diagnostic device for dry eye. LacryDiag is an ocular surface analyzer that is CE marked and is approved by the FDA. The device, which is Quantel Medical’s first product in the dry eye market, complies with the dry eye diagnosis recommendations established in the DEWS II report.
It offers a fast and complete analysis of the three tear film layers with 4 non-contact exams:
- Interferometry: diagnosis of the lipid layer
- Noninvasive Break-Up Time (N.I.B.U.T.): diagnosis of the mucin layer
- Tear meniscus: diagnosis of the aqueous layer
- Meibography: diagnosis of the meibomian glands
“Dry eye is a real public health problem but the symptoms are often misunderstood. As a multifactorial pathology that results from damage to the tear film due, this pathology is often underdiagnosed and underestimated, Jean-Marc Gendre, CEO Quantel Medical, said in a company news release. With LacryDiag, ophthalmologists are now able to diagnosis in a few minutes the three tear film layers to select a personalized treatment for the patient.”